Carbon monoxide releasing molecule-2 attenuated ischemia/reperfusion- induced apoptosis in cardiomyocytes via a mitochondrial pathway

Molecular Medicine Reports

Volumn 9, Issue 2, 2014, Pages 754-762

  Zhao, Shen ^a,b   Lin, Qingming ^a,b   Li, Heng ^a,c   He, Yumin ^a   Fang, Xiangshao ^a   Chen, Feng ^b   Chen, Changwei ^c   Huang, Zitong ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b FUJIAN MEDICAL UNIVERSITY   (China)

^c Taiping People's Hospital of Dongguan)   (China)

Author keywords

Apoptosis; Carbon monoxide; Cardiomyocytes; Ischemia reperfusion; Mitochondrion

Indexed keywords

ANIMALS; APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; CARBON MONOXIDE; CASPASE 3; CYTOCHROMES C; GENE EXPRESSION REGULATION; HUMANS; METABOLIC NETWORKS AND PATHWAYS; MITOCHONDRIA; MYOCYTES, CARDIAC; ORGANOMETALLIC COMPOUNDS; RATS; REPERFUSION INJURY;

EID: 84893848267     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1861     Document Type: Article

References (35)

1. Bialik S, Cryns VL, Drincic A, Miyata S, Wollowick AL, Srinivasan A and Kitsis RN: The mitochondrial apoptotic pathway is activated by serum and glucose deprivation in cardiac myocytes. Circ Res 85: 403-414, 1999.
2. Radhakrishnan J, Wang S, Ayoub IM, Kolarova JD, Levine RF and Gazmuri RJ: Circulating levels of cytochrome c after resuscitation from cardiac arrest: a marker of mitochondrial injury and predictor of survival. Am J Physiol Heart Circ Physiol 292: H767-H775, 2007.
3. Li H, Fang X, Yang Z, et al: Ischemia hypothermia improved contractility under normothermia reperfusion in the model of cultured cardiomyocyte. In Vitro Cell Dev Biol Anim 48: 284-292, 2012.
4. Di Lisa F, Canton M, Menabò R, Kaludercic N and Bernardi P: Mitochondria and cardioprotection. Heart Fail Rev 12: 249-260, 2007.
5. Danial NN and Korsmeyer SJ: Cell death: critical control points. Cell 116: 205-219, 2004.
6. Chipuk JE and Green DR: How do BCL-2 proteins induce mitochondrial outer membrane permeabilization? Trends Cell Biol 18: 157-164, 2008.
7. Kubli DA, Ycaza JE and Gustafsson AB: Bnip3 mediates mitochondrial dysfunction and cell death through Bax and Bak. Biochem J 405: 407-415, 2007.
8. Ren D, Tu HC, Kim H, et al: BID, BIM, and PUMA are essential for activation of the BAX-and BAK-dependent cell death program. Science 330: 1390-1393, 2010.
9. Roy SS, Ehrlich AM, Craigen WJ and Hajnóczky G: VDAC2 is required for truncated BID-induced mitochondrial apoptosis by recruiting BAK to the mitochondria. EMBO Rep 10: 1341-1347, 2009.
10. Motterlini R and Otterbein LE: The therapeutic potential of carbon monoxide. Nat Rev Drug Discov 9: 728-743, 2010.
11. Queiroga CS, Almeida AS and Vieira HL: Carbon monoxide targeting mitochondria. Biochem Res Int 2012: 749845, 2012.
12. Almeida AS, Queiroga CS, Sousa MF, Alves PM and Vieira HL: Carbon monoxide modulates apoptosis by reinforcing oxidative metabolism in astrocytes: role of Bcl-2. J Biol Chem 287: 10761-10770, 2012.
13. Conde de la Rosa L, Vrenken TE, Hannivoort RA, et al: Carbon monoxide blocks oxidative stress-induced hepatocyte apoptosis via inhibition of the p54 JNK isoform. Free Radic Biol Med 44: 1323-1333, 2008.
14. Bannenberg GL and Vieira HL: Therapeutic applications of the gaseous mediators carbon monoxide and hydrogen sulfide. Expert Opin Ther Pat 19: 663-682, 2009.
15. Motterlini R: Carbon monoxide-releasing molecules (CO-RMs): vasodilatory, anti-ischaemic and anti-inflammatory activities. Biochem Soc Trans 35: 1142-1146, 2007.
16. Katada K, Bihari A, Mizuguchi S, et al: Carbon monoxide liberated from CO-releasing molecule (CORM-2) attenuates ischemia/reperfusion (I/R)-induced inflammation in the small intestine. Inflammation 33: 92-100, 2010.
17. Caumartin Y, Stephen J, Deng JP, et al: Carbon monoxide-releasing molecules protect against ischemia-reperfusion injury during kidney transplantation. Kidney Int 79: 1080-1089, 2011.
18. Gomez LA, Alekseev AE, Aleksandrova LA, Brady PA and Terzic A: Use of the MTT assay in adult ventricular cardiomyocytes to assess viability: effects of adenosine and potassium on cellular survival. J Mol Cell Cardiol 29: 1255-1266, 1997.
19. Cheng EH, Sheiko TV, Fisher JK, Craigen WJ and Korsmeyer SJ: VDAC2 inhibits BAK activation and mitochondrial apoptosis. Science 301: 513-517, 2003.
20. Ren D, Kim H, Tu HC, et al: The VDAC2-BAK rheostat controls thymocyte survival. Sci Signal 2: ra48, 2009.
21. Wei MC, Zong WX, Cheng EH, et al: Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292: 727-730, 2001.
22. Wei MC, Lindsten T, Mootha VK, et al: tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. Genes Dev 14: 2060-2071, 2000.
23. Cheng EH, Wei MC, Weiler S, Flavell RA, Mak TW, Lindsten T and Korsmeyer SJ: BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX-and BAK-mediated mitochondrial apoptosis. Mol Cell 8: 705-711, 2001.
24. Kim H, Rafiuddin-Shah M, Tu HC, Jeffers JR, Zambetti GP, Hsieh JJ and Cheng EH: Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies. Nat Cell Biol 8: 1348-1358, 2006.
25. Karbowski M, Norris KL, Cleland MM, Jeong SY and Youle RJ: Role of Bax and Bak in mitochondrial morphogenesis. Nature 443: 658-662, 2006.
26. Youle RJ and Strasser A: The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 9: 47-59, 2008.
27. Shoshan-Barmatz V, Keinan N and Zaid H: Uncovering the role of VDAC in the regulation of cell life and death. J Bioenerg Biomembr 40: 183-191, 2008.
28. Trumbeckaite S, Kincius M, Preidis A, Preidiene M, Veikutis V, Borutaite V and Gulbinas A: Effects of ischemia-reperfusion and pretreatment with mildronate on rat liver mitochondrial function. Pharmacol Rep 61: 859-869, 2009.
29. Venditti P, Masullo P and Di Meo S: Effects of myocardial ischemia and reperfusion on mitochondrial function and susceptibility to oxidative stress. Cell Mol Life Sci 58: 1528-1537, 2001.
30. Chen Q, Moghaddas S, Hoppel CL and Lesnefsky EJ: Reversible blockade of electron transport during ischemia protects mitochondria and decreases myocardial injury following reperfusion. J Pharmacol Exp Ther 319: 1405-1412, 2006.
31. Elimadi A, Settaf A, Morin D, Sapena R, Lamchouri F, Cherrah Y and Tillement JP: Trimetazidine counteracts the hepatic injury associated with ischemia-reperfusion by preserving mitochondrial function. J Pharmacol Exp Ther 286: 23-28, 1998.
32. Clark JE, Naughton P, Shurey S, et al: Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule. Circ Res 93: e2-e8, 2003.
33. Zhang X, Shan P, Alam J, Davis RJ, Flavell RA and Lee PJ: Carbon monoxide modulates Fas/Fas ligand, caspases, and Bcl-2 family proteins via the p38alpha mitogen-activated protein kinase pathway during ischemia-reperfusion lung injury. J Biol Chem 278: 22061-22070, 2003.
34. Sandouka A, Fuller BJ, Mann BE, Green CJ, Foresti R and Motterlini R: Treatment with CO-RMs during cold storage improves renal function at reperfusion. Kidney Int 69: 239-247, 2006.
35. Lo Iacono L, Boczkowski J, Zini R, Salouage I, Berdeaux A, Motterlini R and Morin D: A carbon monoxide-releasing molecule (CORM-3) uncouples mitochondrial respiration and modulates the production of reactive oxygen species. Free Radic Biol Med 50: 1556-1564, 2011.